Dr. David Parker plays both offense and defense when protecting clients' intellectual property assets.  As co-head of the Firm's Intellectual Property and Technology Department, as well as the Austin leader of one of the largest biotech patent groups in the country, Dr. Parker places a premium on the strategy and management of intellectual property portfolios.

From the moment of innovation to the ultimate marketplace, Dr. Parker maps out a course designed not only to provide protection for future manufacturing and marketing, but also to impede competitors from entering the game, thereby ensuring his clients have a clear path to market.

In addition to his law practice, Dr. Parker currently serves as the Vice President of Intellectual Property of Introgen Therapeutics, a gene therapy company involved in clinical trials of genetic based anti-cancer therapies.

Should a legal action become necessary to safeguard a client, Dr. Parker has the litigation experience to take the case to trial.

• Represented a major biotechnology reagent company in a multiple jurisdiction patent infringement case involving biotech tools for genetic engineering. 
• Lead counsel for a major seed company as plaintiff in connection with six related transgenic corn technology litigations industry in multiple jurisdictions involving the entire corn seed industry.
• Guides a leading biopharmaceutical company in patent-related aspects of its biological licensure application (BLA) to the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA).
• Manages and oversees the patent portfolio of a leading biopharmaceutical company and numerous universities and biopharmaceutical research organizations.
• Obtained a substantial settlement as lead litigation counsel representing a major university in a patent infringement action involving pharmaceutical products.
• Obtained a substantial settlement as associate litigation counsel representing a major university in a patent infringement action involving pet food flavoring agents.
• Represented a major biopharmaceutical company as plaintiff and defendant in related patent infringement cases involving one of the first biopharmaceutical products.
• Served as lead U.S. counsel in successfully defending a leading biopharmaceutical company in six European oppositions and appeals before the Technical Board of Appeals of the EPO involving related biopharmaceutical patents.
• Twice received a favorable ruling from the Court of Appeals for the Federal Circuit in Brown v. Barbacid, a seminal interference matter representing Nobel laureates and their technology directed to an important new class of cancer therapeutics.
• Successfully represented a major cancer research and treatment center in Federal District Court and before the Court of Appeals for the Federal Circuit in obtaining a dismissal of a patent and contract matter under the 11th Amendment to the Constitution.

• American Intellectual Property Law Association (AIPLA)
• Association of University Technology Managers (AUTM)
• Austin Intellectual Property Law Association (Austin IPLA)
• American Bar Association
• State Bar of Texas
• University of Texas School of Law, Adjunct Professor of a patent law and strategy workshop (1994 - 2007)

• The Best Lawyers in America, Intellectual Property Law
• Chambers & Partners, USA., ranked among the top attorneys in Intellectual Property Practice Field in Texas
• “Peer Review Rated,” LexisNexis, Martindale Hubbell
• “Texas Super Lawyers,” Intellectual Property Law, Texas Monthly magazine, 2005, 2006, 2007 

• "Intellectual Property 'Must Dos' for Technology Companies," Bioprocessing Journal, September/October 2004
• "Patent Infringement Exemptions for Life Science Research," Houston Journal of International Law, Vol. 16, No. 3, pp. 615-663, Spring 1994
• "Biotechnology Patent Practice After Amgen and Scripps Clinic," Arnold White & Durkee Legal Update, May 1991
• "Managing Patent Rights - Concerns of the Biotechnology Venture and Investor," Commercializing Biotechnology in the Global Economy, April 1990
• "Only Some Prior Knowledge is Prior Art to Patents," Arnold White & Durkee Legal Update, October 1987

• "New PTO Rules Relating to Continuations and Claims," Fulbright & Jaworski L.L.P. Web Seminar, September, 2007
• "Intellectual Property Portfolio Development and Management," Wilbio Presentation, 2005
• "From Provisional Applications to Litigation," The University of Texas School of Law 5th Annual Advanced Patent Law Institute, Austin, Texas, November 2000
• "The Written Description Requirement: A Doctrine in Transition," The University of Texas School of Law 4th Annual Advanced Patent Law Institute and The Southwestern Legal Foundation 37th Annual Institute on Patent Law, Dallas, Texas, November 1999
• "Research Exemptions to Patent Infringement," The University of Texas School of Law 3rd Annual Advanced Patent Law Institute, Austin, Texas, November 1998
• "Enablement, Scope and Infringement in Biotechnology Cases," The University of Texas School of Law 2nd Annual Advanced Patent Law Institute, Austin, Texas, November 1997
• "Recent Developments in Biotechnology Patent Case Law," The University of Texas School of Law Advanced Patent Law Institute, Austin, Texas, November 1996
• "Current Issues in Biotechnology Patent Practice," Fourth Annual Biotechnology Law Institute, San Francisco, California, 1988

1986 - J.D., The University of Texas School of Law
1981 - Ph.D., Molecular Pharmacology and Genetic Engineering, Baylor College of Medicine
1976 - B.A., Honors, Plan II, The University of Texas

Dr. Parker was admitted to practice law in Texas in 1986. In addition, he is admitted to practice before the United States Patent and Trademark Office, the Western and Southern Districts of Texas, the Northern District of California, the Court of Appeals for the Federal Circuit, and the U.S. Supreme Court.

After receiving his Ph.D. from Baylor College of Medicine, Dr. Parker became a faculty member of the school. His faculty position included a joint appointment to the Bristol-Baylor Labs, a division of Bristol Laboratories, and his research focused on the characterization of gene readouts in malignancies and genetic reprogramming of neoplastic cells.

In addition to being a talented doctor and attorney, Dr. Parker is a multi-faceted individual with a wide range of interests. A devoted father of three and active in his church, he is also an accomplished voice student, an impressive dancer, a dedicated soccer coach, an avid golfer and history buff.

• Bethany Lutheran Church, LCMS, Elder (1998 – 2002), Praise Team (2001-2004), Sunday School Teacher (2005 to 2006)
• Greater Austin Chamber of Commerce
• St. Stephen's Episcopal School, Board of Trustees (1994 - 2000)
• Westlake Youth Soccer Association, Coach and Team Manager (2003 to present)
• M.D. Anderson Cancer Center, Technology Review Committee (2005 to 2007)